🏛️ Verified NIH Record • Updated 2026-05-05
Assessing Claims of Cannabis as an Anti-cancer Agent (CATA) (NCT07107607)
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: HealthPartners Institute
🩺 Plain-English Summary (8th-Grade Level)
The purpose of the study is to find out how cannabis may help control cancer growth by reviewing medical records of patients who report cannabis helped treat their cancer.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (3 items) and avoid the listed exclusions (4 items).
Location: HealthPartners Institute Cancer Research Center — Saint Louis Park, Minnesota
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- does not have cancer
- has not used any type of cannabis/marijuana, including those with CBD and/or THC to treat their cancer
- does not believe that cannabis has either stopped the tumor from growing and/or caused a cancer antigen blood marker to remain stable or cannabis has shrunken the tumor and/or caused reduction in a cancer antigen blood marker
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- HealthPartners Institute Cancer Research Center — Saint Louis Park, Minnesota
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.